Systematic identification of regulatory proteins critical for T-cell activation

Journal of Biology

Volumn 2, Issue 3, 2003, Pages

  Chu, Peter ^a   Pardo, Jorge ^a   Zhao, Haoran ^a   Li, Connie C ^a,d   Pali, Erlina ^a   Shen, Mary M ^a   Qu, Kunbin ^a   Yu, Simon X ^a   Huang, Betty C B ^a   Yu, Peiwen ^a,d   Masuda, Esteban S ^a   Molineaux, Susan M ^a   Kolbinger, Frank ^b   Aversa, Gregorio ^c   De Vries, Jan ^c   Payan, Donald G ^a   Liao, X Charlene ^a,e  

^a RIGEL PHARMACEUTICALS INC   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Novartis Forschungsinstitut GmbH   (Austria)

^d EXELIXIS INC   (United States)

^e GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A RAF 1 PROTEIN KINASE; ADAPTOR PROTEIN; ALPHA2 INTEGRIN; CD69 ANTIGEN; CELL MEMBRANE PROTEIN; CELL PROTEIN; COMPLEMENTARY DNA; CYTOPLASM PROTEIN; EDG1 PROTEIN; G PROTEIN COUPLED RECEPTOR; INTEGRIN; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR ALPHA; LIGASE; MUTANT PROTEIN; NUCLEAR PROTEIN; P21 ACTIVATED KINASE 2; PHOSPHOLIPASE C GAMMA1; PROTEIN KINASE; PROTEIN KINASE LCK; PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; REGULATOR PROTEIN; T LYMPHOCYTE RECEPTOR; TRAC 1 PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; LECTIN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN; T LYMPHOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL ASSAY; CYTOKINE PRODUCTION; DNA ISOLATION; DNA LIBRARY; FLOW CYTOMETRY; GENE EXPRESSION; GENE FREQUENCY; GENE TECHNOLOGY; GENETIC ANALYSIS; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREGULATION; LEUKEMIA CELL LINE; LYMPHOCYTE FUNCTION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; RETROVIRUS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TECHNIQUE; UPREGULATION; CHEMISTRY; GENE; GENE EXPRESSION REGULATION; JURKAT CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; T LYMPHOCYTE; TUMOR CELL LINE;

UNIDENTIFIED RETROVIRUS;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GENES; HUMANS; JURKAT CELLS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; PROTEINS; RECEPTORS, ANTIGEN, T-CELL; RESEARCH DESIGN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UP-REGULATION;

EID: 0242624487     PISSN: 14785854     EISSN: 14754924     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Marrack P, Kappler J: The T cell receptor. Science 1987, 238:1073-1079.
2. Weiss A, Stobo JD: Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J Exp Med 1984, 160:1284-1299.
3. Dustin ML, Chan AC: Signaling takes shape in the immune system. Cell 2000, 103:283-294.
4. Kane LP, Lin J, Weiss A: Signal transduction by the TCR for antigen. Curr Opin Immunol 2000, 12:242-249.
5. Singer AL, Koretzky GA: Control of T cell function by positive and negative regulators. Science 2002, 296:1639-1640.
6. Ziegler SF, Ramsdell F, Alderson MR: The activation antigen CD69. Stem Cells 1994, 12:456-465,
7. Yablonski D, Kuhne MR, Kadlecek T, Weiss A: Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell. Science 1998, 281:413-416.
8. Zhang W, Irvin BJ, Trible RP, Abraham RT, Samelson LE: Functional analysis of LAT in TCR-mediated signaling pathways using a LAT-deficient Jurkat cell line. Int Immunol 1999, 11:943-950.
9. Baron U, Gossen M, Bujard H: Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 1997, 25:2723-2729.
10. Qian D, Mollenauer MN, Weiss A: Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling. J Exp Med 1996, 183:611-620.
11. Lin J, Weiss A: T cell receptor signalling. J Cell Sci 2001, 114:243-244.
12. Straus DB, Weiss A: Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992, 70:585-593.
13. Secrist JP, Karnitz L, Abraham RT: T-cell antigen receptor ligation induces tyrosine phosphorylation of phospholipase C-gamma 1. J Biol Chem 1991, 266:12135-12139.
14. Irvin BJ, Williams BL, Nilson AE, Maynor HO, Abraham RT: Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line. Mol Cell Biol 2000, 20:9149-9161.
15. Hla T, Maciag T: An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem 1990, 265:9308-9313.
16. Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R, Spiegel S, Hla T: Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998, 279:1552-1555.
17. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J Biol Chem 1998, 273:27104-27110.
18. Lim L, Manser E, Leung T, Hall C: Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways. Eur J Biochem 1996, 242:171-185.
19. Bokoch GM: Biology of the p21-activated kinases. Annu Rev Biochem 2003, 72:743-781.
20. Martin GA, Bollag G, McCormick F, Abo A: A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J 1995, 14:1970-1978.
21. Teo M, Manser E, Lim L: Identification and molecular cloning of a p21 cdc42/rac1-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. J Biol Chem 1995, 270:26690-26697.
22. Rudel T, Bokoch GM: Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997, 276:1571-1574.
23. Rudel T, Zenke FT, Chuang TH, Bokoch GM: p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells. J Immunol 1998, 160:7-11.
24. Bubeck Wardenburg J, Pappu R, Bu JY, Mayer B, Chernoff J, Straus D, Chan AC: Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76. Immunity 1998, 9:607-616.
25. Yablonski D, Kane LP, Qian D, Weiss A: A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK. EMBO J 1998, 17:5647-5657.
26. Margolis B, Silvennoinen O, Comoglio F, Roonprapunt C, Skolnik E, Ullrich A, Schlessinger J: High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. Proc Natl Acad Sci USA 1992, 89:8894-8898.
27. Han DC, Shen TL, Guan JL: The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene 2001, 20:6315-6321.
28. Joazeiro CA, Weissman AM: RING finger proteins: mediators of ubiquitin ligase activity. Cell 2000, 102:549-552.
29. Ben-Neriah Y: Regulatory functions of ubiquitination in the immune system. Nat Immunol 2002, 3:20-26.
30. Sawasdikosol S, Pratt JC, Meng W, Eck MJ, Burakoff SJ: Adapting to multiple personalities: Cbl is also a RING finger ubiquitin ligase. Biochim Biophys Acta 2000, 1471:M1-M12.
31. Demo SD, Masuda E, Rossi AB, Throndset BT, Gerard AL, Chan EH, Armstrong RJ, Fox BP, Lorens JB, Payan DG, et al.: Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. Cytometry 1999, 36:340-348.
32. Kveberg L, Bryceson Y, Inngjerdingen M, Rolstad B, Maghazachi AA: Sphingosine 1 phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases. Eur J Immunol 2002, 32:1856-1864.
33. Idzko M, Panther E, Corinti S, Morelli A, Ferrari D, Herouy Y, Dichmann S, Mockenhaupt M, Gebicke-Haerter P, Di Virgilio F, et al.: Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J 2002, 16:625-627.
34. Frantz JD, Giorgetti-Peraldi S, Ottinger EA, Shoelson SE: Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. J Biol Chem 1997, 272:2659-2667.
35. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, et al.: The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002, 277:21453-21457.
36. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, et al.: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296:346-349.
37. Izquierdo M, Bowden S, Cantrell D: The role of Raf-1 in the regulation of extracellular signal-regulated kinase 2 by the T cell antigen receptor. J Exp Med 1994, 180:401-406.
38. Siegel JN, June CH, Yamada H, Rapp UR, Samelson LE: Rapid activation of C-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells. J Immunol 1993, 151:4116-4127.
39. Reif K, Buday L, Downward J, Cantrell DA: SH3 domains of the adapter molecule Grb2 complex with two proteins in T cells: the guanine nucleotide exchange protein Sos and a 75-kDa protein that is a substrate for T cell antigen receptor-activated tyrosine kinases. J Biol Chem 1994, 269:14081-14087.
40. Buday L, Egan SE, Rodriguez Viciana P, Cantrell DA, Downward J: A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells. J Biol Chem 1994, 269:9019-9023.
41. Brown A, Wang X, Sawai E, Cheng-Mayer C: Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex. J Virol 1999, 73:9899-9907.
42. Renkema GH, Manninen A, Mann DA, Harris M, Saksela K: Identification of the Nef-associated kinase as p21-activated kinase 2. Curr Biol 1999, 9:1407-1410.
43. Arora VK, Molina RP, Foster JL, Blakemore JL, Chernoff J, Fredericksen BL, Garcia JV: Lentivirus Nef specifically activates Pak2. J Virol 2000, 74:11081-11087.
44. Lorens JB, Sousa C, Bennett MK, Molineaux SM, Payan DG: The use of retroviruses as pharmaceutical tools for target discovery and validation in the field of functional genomics. Curr Opin Biotechnol 2001, 12:613-621.
45. Xu X, Leo C, Jang Y, Chan E, Padilla D, Huang BC, Lin T, Gururaja T, Hitoshi Y, Lorens JB, et al.: Dominant effector genetics in mammalian cells. Nat Genet 2001, 27:23-29.
46. Holland SJ, Liao XC, Mendenhall MK, Zhou X, Pardo J, Chu P, Spencer C, Fu A, Sheng N, Yu P, et al.: Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling. J Exp Med 2001, 194:1263-1276.
47. Kinsella TM, Ohashi CT, Harder AG, Yam GC, Li W, Peelle B, Pali ES, Bennett MK, Molineaux SM, Anderson DA, et al.: Retrovirally delivered random cyclic peptide libraries yield inhibitors of interleukin-4 signaling in human B cells. J Biol Chem 2002, 277:37512-37518.
48. Lorens JB, Bennett MK, Pearsall DM, Throndset WR, Rossi AB, Armstrong RJ, Fox BP, Chan EH, Luo Y, Masuda E, et al.: Retroviral delivery of peptide modulators of cellular functions. Mol Ther 2000, 1:438-447.
49. Swift SE, Lorens JB, Achacoso P, Nolan GP: Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. In Current Protocols in Immunology, vol 10.17C. Edited by Coligan RCJE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Hoboken, NJ: John Wiley and Sons; 2000:1-17.
50. Hitoshi Y, Lorens J, Kitada SI, Fisher J, LaBarge M, Ring HZ, Francke U, Reed JC, Kinoshita S, Nolan GP: Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 1998, 8:461-471.
51. GenBank [http://www.ncbi.nlm.nih.gov/Genbank/]
52. Liu H, Rhodes M, Wiest DL, Vignali DA: On the dynamics of TCR:CD3 complex cell surface expression and down-modulation. Immunity 2000, 13:665-675.
53. Law CL, Sidorenko SP, Chandran KA, Draves KE, Chan AC, Weiss A, Edelhoff S, Disteche CM, Clark EA: Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. J Biol Chem 1994, 269:12310-12319.
54. Williams BL, Schreiber KL, Zhang W, Wange RL, Samelson LE, Leibson PJ, Abraham RT: Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol Cell Biol 1998, 18:1388-1399.
55. Fargnoli J, Burkhardt AL, Laverty M, Kut SA, van Oers NS, Weiss A, Bolen JB: Syk mutation in Jurkat E6-derived clones results in lack of p72syk expression. J Biol Chem 1995, 270:26533-26537.
56. Shultz LD, Rajan TV, Greiner DL: Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol 1997, 15:302-307.
57. Ravetch JV, Lanier LL: Immune inhibitory receptors. Science 2000, 290:84-89.
58. Yang J, Cheng Z, Niu T, Liang X, Zhao ZJ, Zhou GW: Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1. J Biol Chem 2000, 275:4066-4071.
59. Brdicka T, Pavlistova D, Leo A, Bruyns E, Korinek V, Angelisova P, Scherer J, Shevchenko A, Hilgert I, Cerny J, et al.: Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med 2000, 191:1591-1604.
60. Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, Nagai K, Tarakhovsky A, Okada M: Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 2000, 404:999-1003.
61. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE: LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998, 92:83-92.
62. Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Horejsi V, Schraven B, Rolstad B, Mustelin T, Tasken K: Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts. J Biol Chem 2001, 276:29313-29318.
63. Hermiston ML, Xu Z, Majeti R, Weiss A: Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J Clin Invest 2002, 109:9-14.
64. Itoh K, Sakakibara M, Yamasaki S, Takeuchi A, Arase H, Miyazaki M, Nakajima N, Okada M, Saito T: Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. J Immunol 2002, 168:541-544.
65. Kolch W: Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000, 351:289-305.
66. Izquierdo M, Bowden S, Cantrell D: The role of Raf-1 in the regulation of extracellular signal-regulated kinase 2 by the T cell antigen receptor. J Exp Med 1994, 180:401-406.
67. Gupta S, Weiss A, Kumar G, Wang S, Nel A: The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. J Biol Chem 1994, 269:17349-17357.
68. Kolch W, Heidecker G, Lloyd P, Rapp UR: Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 1991, 349:426-428.
69. Schaap D, van der Wal J, Howe LR, Marshall CJ, van Blitterswijk WJ: A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21 ras. J Biol Chem 1993, 268:20232-20236.
70. Cool DE, Tonks NK, Charbonneau H, Walsh KA, Fischer EH, Krebs EG: cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. Proc Natl Acad Sci USA 1989, 86:5257-5261.
71. Hao L, Tiganis T, Tonks NK, Charbonneau H: The noncatalytic C-terminal segment of the T cell protein tyrosine phosphatase regulates activity via an intramolecular mechanism. J Biol Chem 1997, 272:29322-29329.
72. Liu Y, Wei SH, Ho AS, de Waal Malefyt R, Moore KW: Expression cloning and characterization of a human IL-10 receptor. J Immunol 1994, 152:1821-1829.
73. Takada Y, Hemler ME: The primary structure of the VLA-2/collagen receptor alpha 2 subunit (platelet GP1a): homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 1989, 109:397-407.
74. Kolanus W, Seed B: Integrins and inside-out signal transduction: converging signals from PKC and PIP3. Curr Opin Cell Biol 1997, 9:725-731.
75. Obergfell A, Judd BA, del Pozo MA, Schwartz MA, Koretzky GA, Shattil SJ: The molecular adapter SLP-76 relays signals from platelet integrin alpha11bbeta3 to the actin cytoskeleton. J Biol Chem 2001, 276:5916-5923.
76. Peterson EJ, Woods ML, Dmowski SA, Derimanov G, Jordan MS, Wu JN, Myung PS, Liu QH, Pribila JT, Freedman BD, et al.: Coupling of the TCR to integrin activation by Slap-130/Fyb. Science 2001, 293:2263-2265.
77. Siliciano JD, Morrow TA, Desiderio SV: itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci USA 1992, 89:11194-11198.
78. Liao XC, Littman DR: Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 1995, 3:757-769.
79. Woods ML, Kivens WJ, Adelsman MA, Qiu Y, August A, Shimizu Y: A novel function for the Tec family tyrosine kinase Itk in activation of beta 1 integrins by the T-cell receptor. EMBO J 2001, 20:1232-1244.
80. Ivaska J, Reunanen H, Westermarck J, Koivisto L, Kahari VM, Heino J: Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail. J Cell Biol 1999, 147:401-416.
81. Osborne MA, Dalton S, Kochan JP: The yeast tribrid system - genetic detection of trans-phosphorylated ITAM-SH2-interactions. Biotechnology 1995, 13:1474-1478.
82. Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI: Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1995, 92:11618-11622.
83. Yokouchi M, Suzuki R, Masuhara M, Komiya S, Inoue A, Yoshimura A: Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. Oncogene 1997, 15:7-15.
84. Takaki S, Sauer K, Iritani BM, Chien S, Ebihara Y, Tsuji K, Takatsu K, Perlmutter RM: Control of B cell production by the adaptor protein Ink. Definition of a conserved family of signal-modulating proteins. Immunity 2000, 13:599-609.
85. Horrevoets AJ, Fontijn RD, van Zonneveld AJ, de Vries CJ, ten Cate JW, Pannekoek H: Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood 1999, 93:3418-3431.
86. Kumar D, Whiteside TL, Kasid U: Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein. J Biol Chem 2000, 275:2973-2978.